enfinity energy, LLC and TSI Group have announced an exclusive global distribution partnership for enfinity paraxanthine, a metabolite of caffeine supported by 23 filed patents, four human clinical studies, and a robust body of preclinical work.
In a Brazilian clinical trial, padel athletes who ingested caffeine showed improved efficiency in specific strokes compared to athletes who ingested the placebo.
Caffeinated weight loss supplements that have been seized by the Brazilian Federal Police were analyzed. Investigators found that some contained up to 120% more caffeine that stated on the packaging.